Bibliography
- World Health Organization. Consumer reporting of adverse drug reactions. WHO Drug Info 2000;14:211-15
- Inch J, Watson MC, Anakwe-Umeh S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Drug Saf 2012;35:807-18
- Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007;63:148-56
- Hazell L, Cornelius V, Hannaford P, et al. How do patients contribute to signal detection? A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK’s Yellow Card Scheme. Drug Saf 2013;36:199-206
- Aagaard L, Nielsen LH, Hansen EH. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf 2009;32:1067-74
- van Hunsel F, Talsma A, van Puijenbroek E, et al. The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiol Drug Saf 2011;20:286-91
- Directive 2010/84/EU of the European Parliament and the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2011/83/EC on the Community code relating to medicinal products for human use. European Parliament and the Council of the European Union 2010. Available from: http://eur-lex.europa.eu/LexUriServ.do?uri=OJ:L:2010:348:0074:0099:EN:PDF [Last accessed 1 December 2013]
- Italian Legislative Decree 20 April 1991. Document Information Ministry. Gazzetta Ufficiale No.133/1991. Available from: http://www.gazzettaufficiale.it/gazzetta/serie_generale/caricaDettaglio?dataPubblicazioneGazzetta=1991-06-08&numeroGazzetta=133 [Last accessed 04 May 2014]
- Italian Medicines Agencies. Modalità di segnalazione delle sospette reazioni avverse ai medicinali. Available from: http://www.agenziafarmaco.gov.it/it/content/modalit%C3%A0-di-segnalazione-delle-sospette-reazioni-avverse-ai-medicinali [Last accessed 1 February 2014]
- Leone R, Moretti U, D’Incau P, et al. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Drug Saf 2013;36:267-76
- European Medicines Agency. ICH topic E2A Clinical safety data management: definitions and standards for expedited reporting 1995. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002749.pdf [Last accessed 20 February 2014]
- Paoletti A, Gallo E, Benemei S, et al. Interactions between Natural Health Products and Oral Anticoagulants: spontaneous Reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med 2011;2011:612150
- Mazzitello C, Esposito S, De Francesco AE, et al. Pharmacovigilance in Italy: an overview. J Pharmacol Pharmacother 2013;4:S20-8
- Rafaniello C, Lombardo F, Ferrajolo C, et al. Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy. Eur J Clin Pharmacol 2014;70:187-95
- Raucci U, Rossi R, Da Cas R, et al. Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One 2013;8:e68231
- Bianciotto M, Chiappini E, Raffaldi I, et al. Drug use and upper gastrointestinal complications in children: a case-control study. Arch Dis Child 2013;98:218-21
- Ruggiero S, Rafaniello C, Bravaccio C, et al. Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. J Child Adolesc Psychopharmacol 2012;22:415-22
- Parretta E, Ianniello B, Ferrazin F, et al. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. Vaccine 2011;29:3708-13
- Bertuola F, Morando C, Menniti-Ippolito F, et al. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf 2010;33:65-72
- Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergency-department visits for outpatient adverse drug events. Eur J Clin Pharmacol 2009;65:721-8
- Capuano A, Noviello S, Avolio A, et al. Antibiotic prophylaxis in surgery: an observational prospective study conducted in a large teaching hospital in Naples. J Chemother 2006;18:293-7
- Mazzeo F, Capuano A, Motola G, et al. Antibiotic use in an Italian university hospital. J Chemother 2002;14:332-5
- Motola G, Russo F, Mazzeo F, et al. Over-the-counter oral nonsteroidal anti-inflammatory drugs: a pharmacoepidemiologic study in southern Italy. Adv Ther 2001;18:216-22
- Mazzeo F, Motola G, Rossi S, et al. Management of hypertension by general practitioners: an Italian observational study. Adv Ther 2001;18:122-30
- Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clin Epidemiol 2009;1:75-92
- Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf 2013;36:317-28
- Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003;58:707-14
- Aspinall MB, Whittle J, Aspinall SL, et al. Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital. Am J Health Syst Pharm 2002;59:841-5
- Herxheimer A, Crombag R, Leonardo Alves T. Direct reporting of adverse drug reactions: a fifteen-country survey and literature review. Health Action International Europe 2010. Available from: http://www.haiweb.org/14012010/14Jan2010ReportDirectPatientReportingofADRsFINAL.pdf [Last accessed 1 December 2013]
- Monitoring Medicines. Review of direct patient reporting of adverse drug reactions. Survey report 2010. Available from: http://www.monitoringmedicines.org/graphics/26652.pdf [Last accessed 11 June 2014]
- Yellow card report. Medicines and Healthcare products Regulatory Agency. Available from: http://yellowcard.mhra.gov.uk/_assets/files/Member-of-Public-Yellow-CardReporting-form.pdf [Last accessed 12 December 2013]
- Spanish Medicines Agency. Información para las notificaciones de sospechas de reacciones adversas a medicamentos por parte de ciudadanos. Available from: http://www.aemps.gob.es/vigilancia/medicamentosUsoHumano/SEFV-H/NRA-SEFV-H/notificaSospechas-RAM-ciudadanos.htm [Last accessed 12 December 2013]
- McLernon DJ, Bond CM, Hannaford PC, et al. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf 2010;33:775-88
- Perry BA, Turner LW. A prediction model for polypharmacy: are older, educated women more susceptible to an adverse drug event? J Women Aging 2001;13:39-51
- Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol 2008;64:999-1004
- de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf 2008;31:515-24